Answers are grounded in this paper and cite their sources.
Surgery for recurrent glioma provides cytoreduction and tissue for molecularly informed treatment. With mostly heavily pretreated patients involved, it is unclear whether the benefits of repeat surgery outweigh its potential risks.
No takes yet. Share an insight, caveat, or question.
Alhalabi et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: